| 000 | 01861 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516121754.0 | ||
| 264 | 0 | _c20130501 | |
| 008 | 201305s 0 0 eng d | ||
| 022 | _a1932-6203 | ||
| 024 | 7 |
_a10.1371/journal.pone.0048994 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLi, Guang-quan | |
| 245 | 0 | 0 |
_aEffect of dicycloplatin, a novel platinum chemotherapeutical drug, on inhibiting cell growth and inducing cell apoptosis. _h[electronic resource] |
| 260 |
_bPloS one _c2012 |
||
| 300 |
_ae48994 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xchemistry |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aCaspase 3 _xmetabolism |
| 650 | 0 | 4 |
_aCaspase 8 _xmetabolism |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 |
_aGlutamates _xpharmacology |
| 650 | 0 | 4 | _aHep G2 Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMembrane Potential, Mitochondrial _xdrug effects |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 |
_aOrganoplatinum Compounds _xpharmacology |
| 650 | 0 | 4 |
_aPlatinum _xchemistry |
| 650 | 0 | 4 |
_aPoly(ADP-ribose) Polymerases _xmetabolism |
| 650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Death Domain _xmetabolism |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xgenetics |
| 700 | 1 | _aChen, Xing-gui | |
| 700 | 1 | _aWu, Xing-ping | |
| 700 | 1 | _aXie, Jing-dun | |
| 700 | 1 | _aLiang, Yong-ju | |
| 700 | 1 | _aZhao, Xiao-qin | |
| 700 | 1 | _aChen, Wei-qiang | |
| 700 | 1 | _aFu, Li-wu | |
| 773 | 0 |
_tPloS one _gvol. 7 _gno. 11 _gp. e48994 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0048994 _zAvailable from publisher's website |
| 999 |
_c22264835 _d22264835 |
||